Researchers create stem cell model to identify potential targeted epilepsy treatment
In a new study published in the scientific journal Brain, researchers at Children’s Hospital of Philadelphia have used…
In a new study published in the scientific journal Brain, researchers at Children’s Hospital of Philadelphia have used…
Aktieägarna i Fluicell AB (publ), org.nr 556889-3282, kallas härmed till extra bolagsstämma torsdagen den 4 januari 2024 kl….
Today, August 2023, Fluicell publishes the financial report for the period January 1 to June 30, 2023. The…
Building a strong community that contains therapeutic developers, healthcare organizations, and infrastructure and service providers is essential for…
Did you miss the presentation last week by CEO Carolina Trkulja on how Fluicell is transforming how we…
“I see great potential in our technology, and I think we have only scratched the surface of what…
Over the past year, Fluicell has made significant progress in the development of bioprinted tissue-based products for therapeutic…
Tomorrow, we have the honor of hosting a workshop on non-animal models in research and drug development, featuring…
Faithfully replicating the tumor microenvironment is critical for understanding cancer development. In our new application note In our…